CareersInvestorsPressCorporate
Login
  1. Home
  2. Medical Imaging
  3. Angiography
  4. Clinical Software Applications
  5. myEmbolization Guide
Angio for Interventional Oncology

myEmbolization GuideSmart planning for targeted embolization

Embolization is key to relieving symptoms or reducing tumor burden. Patients rely on personalized planning and precise therapy – even as your clinical demands grow. myEmbolization Guide1 enhances workflow efficiency by automating manual tasks and supporting decision-making along the pathway. 

Building on our oncology leadership with our comprehensive portfolio for personalized therapies, our novel myEmbolization Guide empowers you to plan with confidence and navigate precisely – smart planning for targeted embolization.


Courtesy of SLK Clinics, Heilbronn, Germany

Our new AI-powered myEmbolization Guide delivers:

  • easy 3D liver tumor contouring and
  • comprehensive vascular mapping for liver and prostate embolization
  • clear differentiation between feeder and non-feeder vessels
  • full control over the visualized information.
This supports confident planning and precise navigation – while the completely redesigned intuitive user interface guides you every step of the way. The organ-specific algorithm is trained with AI for liver and prostate anatomy using intra-arterially injected DynaCT and CT data. A third, flexible workflow setting is available for embolization procedures in other organs, offering additional support for MRA data. Simply select the appropriate workflow when launching the planning and guidance software. Explore the possibilities!

Clinical workflows

Three distinct workflows to address both specialized and general needs:

Liver workflow2

 

Semi-automatic 3D liver lesion contouring shows the tumor’s true morphology

Target identification

Semi-automatic 3D liver lesion contouring shows the tumor’s true morphology.

Automatic identification of the entire vessel tree with clear differentiation between feeder and non-feeder vessels for confident planning and precise navigation.

Vessel detection

Automatic identification of the entire vessel tree with clear differentiation between feeder and non-feeder vessels for confident planning and precise navigation. Extending the envisioned treatment zone around the tumor initiates an immediate re-computation of the vessel information.
Overlay of planning results on live fluoroscopy images for real-time guidance.

Guidance

Overlay of planning results on live fluoroscopy images for real-time guidance. Easy length adaptation in the visualization of non-feeder vessels reduces information overload.

Prostate workflow3

 

Marking the prostatic gland as a sphere

Target identification

Marking the prostatic gland as a sphere.

Semi-automatic detection of the entire vessel tree with clear differentiation between feeder and non-feeder vessels for confident planning and precise navigation.

Vessel detection

Semi-automatic detection of the entire vessel tree with clear differentiation between feeder and non-feeder vessels for confident planning and precise navigation. Extending the envisioned treatment zone around the prostate initiates an immediate re-computation of the vessel information.
Easy length adaptation in the visualization of non-feeder vessels reduces information overload

Adjustment to clinical needs

Easy length adaptation in the visualization of non-feeder vessels reduces information overload. The mouse-over feature highlights the downstream vessel tree which can be utilized for planning of the optimal treatment position.

Flexible workflow setting4

 

The flexible workflow setting allows you to manually mark the proximal and distal points for vessel detection.

Do you need to perform an embolization on an organ other than the liver or prostate? Then select the general flexible workflow setting. It allows you to manually mark the proximal and distal points for vessel detection.

Customer voices

"Any guidance on the workflow greatly improves the learning experience we can provide to our residents, and it also reduces errors and I think standardization helps a lot in delivering reliable patient care."
Prof. Dr. med. Frank K. Wacker 
President of DeGIR, Germany
1
myEmbolization Guide is under development. Not available for sale in the U.S.A. The products/features (mentioned herein) are pending 510(k) clearance, and are not yet commercially available in the United States.”
​2
Courtesy: SLK Clinics, Heilbronn, Germany; Hannover Medical School, Germany
​3
Courtesy: Alexandria University, Egypt
​4
Courtesy: University Hospital Frankfurt, Germany
5
ARTIS genio floor is pending 510(k) clearance, and is not yet commercially available in the United States.
​6
ARTIS icono.explore floor is pending 510(k) clearance, and is not yet commercially available in the United States.
​7
ARTIS icono.vision is pending 510(k) clearance, and not yet commercially available in the United States. ARTIS icono.vision is an edition of ARTIS icono.
​8
ARTIS pheno.vision is pending 510(k) clearance, and not yet commercially available in the United States. ARTIS pheno.vision is an edition of ARTIS pheno.
The statements by customers of Siemens Healthineers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that othercustomers will achieve the same results
The products/features (mentioned herein) are not commercially available In all countries. Their future availability cannot be guaranteed.